Beyond Viral Control: Tenofovir's Hidden Impact on Blood–Brain Barrier Endothelial Cells
Microcirculation · 2026-07 · 33 (5)
DOI: 10.1111/micc.70079 ↗At a glance
Journal article in Microcirculation, published online on 2026-07-02. Written by Saarah Behardien and 3 co-authors. Institution: Neurobiology Research Group, Department of Medical Biosciences, Faculty of Natural Sciences, University of the Western Cape, Cape Town, South Africa. Major MEDLINE topics: Tenofovir, Blood-Brain Barrier, Endothelial Cells, Anti-HIV Agents. 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: University of the Western Cape Senate Research Funds, Thuthuka National Research Funding.
Abstract (original language)
The blood–brain barrier (BBB) is a dynamic endothelial interface that protects the brain from harmful agents while regulating molecular exchange. Human immunodeficiency virus (HIV) compromises BBB integrity, promoting neurological damage. Antiretroviral (ARV) therapies suppress HIV replication, preventing immune system deterioration and progression to AIDS. Although Tenofovir‐based ARV regimens are vital for HIV treatment and prevention, their impact on cerebrovascular function remains unclear.
Aim
This study examined Tenofovir's effects on murine brain endothelial cells using an in vitro BBB model.
Methods
Brain endothelial cells (bEnd.5) were treated with Tenofovir Disoproxil Fumarate (TDF; 9.8–98 ng/mL) or Tenofovir Alafenamide (TAF; 1–10 ng/mL) for 24–96 h. Cell proliferation, cell cycle progression (via flow cytometry) and monolayer permeability (via Transendothelial Electrical Resistance) were evaluated.
Results
Both TDF and TAF treatments suppressed cell division by S‐phase disruption of the cell cycle and increased monolayer permeability.
Conclusion
These findings suggest that prolonged TDF or TAF exposure compromises BBB integrity by inhibiting endothelial cell division and altering barrier function, which could have implications for HIV‐ARV‐induced neurodegeneration in individuals receiving long‐term Tenofovir‐based therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Neurobiology Research Group, Department of Medical Biosciences, Faculty of Natural Sciences, University of the Western Cape, Cape Town, South Africa.
ORCID profiles: Saarah Behardien, Khayelihle Brian Makhathini, Chontrelle Willemse, David Fisher
Funding
- University of the Western Cape Senate Research Funds
- Thuthuka National Research Funding
Cite
APA
Behardien, S., Makhathini, K. B., Willemse, C., & Fisher, D. (2026). Beyond Viral Control: Tenofovir's Hidden Impact on Blood–Brain Barrier Endothelial Cells. Microcirculation, 33(5). https://doi.org/10.1111/micc.70079
Vancouver
Behardien S, Makhathini KB, Willemse C, Fisher D. Beyond Viral Control: Tenofovir's Hidden Impact on Blood–Brain Barrier Endothelial Cells. Microcirculation. 2026;33(5). doi:10.1111/micc.70079
BibTeX
@article{Behardien2026,
author = {Behardien, Saarah and Makhathini, Khayelihle Brian and Willemse, Chontrelle and Fisher, David},
title = {Beyond Viral Control: Tenofovir's Hidden Impact on Blood–Brain Barrier Endothelial Cells},
journal = {Microcirculation},
year = {2026},
volume = {33},
number = {5},
doi = {10.1111/micc.70079}
}
EUVIMED